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Abstract  
Budding uninhibited by benzimidazole-related 1 (BubR1) is a major factor of the spindle 
assembly checkpoint (SAC), which monitors the accurate separation of sister chromosomes. When 
SAC function is impaired, unequal chromosomal distribution occurs, resulting in aneuploidy. Loss-of-
function mutations in the Bub1b gene, which encodes BubR1, cause premature chromatid separation 
syndrome, a congenital disease, due to impaired SAC function. In addition, BubR1 has SAC-
independent functions, playing roles in cellular processes such as cilia formation and aging, and each 
of its functions appear to be related to human disease. Therefore, I hypothesized that elucidating 
further physiological functions of BubR1 might aid in the discovery of new disease mechanisms in 
humans.  
In the first study, I investigated the relationship between BubR1 and impaired liver 
regeneration due to aging. Delayed liver regeneration after partial hepatectomy (PHx) is frequently 
observed in aged patients, and leads to acute liver injury. Low expression of BubR1 is also reportedly 
involved in aging; however, its effects on liver regeneration have not been investigated. Thus, I 
investigated the effects of BubR1 insufficiency on liver regeneration in mice. Low-BubR1-expressing 
mutant (BubR1L/L) mice displayed delayed recovery of the liver weight-to-body weight ratio and 
increased liver deviation enzyme levels after PHx. Microscopic observation of BubR1L/L mouse livers 
demonstrated an increased number of necrotic hepatocytes and intercalated disc anomalies, resulting 
in widened inter-hepatocyte and perisinusoidal spaces, smaller hepatocytes, and early-stage microvilli 
atrophy. Up-regulation of desmocollin-1 (DSC1) was observed in wild type, but not in BubR1L/L, mice 
after PHx. In addition, BubR1 knockdown caused the down-regulation of DSC1 in a human 
keratinocyte cell line. The data suggest that BubR1 insufficiency resulted in impaired liver 
regeneration through weakened microstructural adaptation against PHx, enhanced transient liver 
failure, and delayed hepatocyte proliferation.  
In the second study, I investigated the contribution of BubR1 to carcinogenesis and tumor 
malignancy. Although there are numerous reports that high BubR1 expression is a poor prognostic 
maker for various tumors and that aneuploidy is observed in these tumors, the relationship between 
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these clinical findings and high BubR1 expression remains unclear. Therefore, I explored why high 
BubR1 expression occurs and how it relates to carcinogenesis and tumor malignancy. First, I 
examined the involvement of p53 signal pathway, a crucial molecule in avoiding aneuploidy, in the 
control of BubR1 expression. KBrO3, an oxidant, caused the activation of p53 signaling pathway and 
suppressed BubR1 expression in human diploid fibroblast MRC5 cells. This suppression was 
dependent on functional p53 and reactive oxygen species. In p53-depleted cells, KBrO3 did not 
suppress BubR1 expression and caused increases in both binucleated cells and cells with > 4N DNA 
content. BubR1 downregulation suppressed KBrO3-induced binucleation and cells with > 4N DNA 
content in p53 knockdown cells, suggesting that BubR1 contributes to enhanced polyploidization. In 
an analysis of 182 gastric cancer specimens, BubR1 expression was significantly higher p53 was 
positively stained, which indicates loss of p53 function (p= 0.0019). Moreover, p53 positivity and 
high BubR1 expression in tumors were significantly correlated with aneuploidy (p=0.0065). These 
observations suggest that p53 deficiency may lead to failure to downregulate BubR1, and p53 
deficiency and BubR1 accumulation could contribute to gastric carcinogenesis associated with 
aneuploidy. 
These studies reinforce the notion that BubR1 is associated with biologically important 
processes, both as part of the SAC and independently. Since abnormal expression of BubR1 results in 
various diseases, it is considered a useful target for drug development. In the future, it will be 
necessary to elucidate the factors affecting each function downstream of BubR1. Moreover, further 
clarification of the relationships between different BubR1 functions at the molecular level will lead to 
the elucidation of new disease mechanisms, and contribute to the development of effective treatments 
for BubR1-related diseases. 
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Abbreviations  
BubR1: budding uninhibited by benzimidazole-related 1 
SAC: spindle assembly checkpoint 
APC/C: anaphase-promoting complex/cyclosome 
CDC20: cell-division cycle protein 20 
CDK1: cyclin-dependent kinase 1 
MCC: mitotic checkpoint complex 
Mad2: mitotic arrest deficient 2 
Bub3: budding uninhibited by benzimidazoles 3 homolog 
Mad3: mitotic arrest deficient 3 
PCS: premature chromatid separation 
MVA: mosaic variegated aneuploidy 
PHx: partial hepatectomy 
ID: intercalated disc  
DSC1: desmocollin-1  
ALT: alanine:2-oxoglutarate aminotransferase 
AST: asparate:2-oxoglutarate aminotransferase 
LDH: lactate dehydrogenase 
T-BIL: total bilirubin 
D-BIL: direct bilirubin 
I-BIL: indirect bilirubin 
TBA: total bile acid 
ALP: alkaline phosphatase 
IDs: intercalated disks 
DICD: detachment induced cell death 
mRNA: messenger ribonucleic acid 
siRNA: small interfering RNA 
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PCR: polymerase chain reaction  
HaCaT cells: human keratinocyte cell line  
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General Introduction 
Cell division is necessary for the development and maintenance of life, and occurs through 
the replication and even distribution of cellular components to two daughter cells. For the survival and 
evolution of species, division must occur accurately, and thus each step is controlled by cell cycle 
control mechanisms. One of these control mechanisms, the spindle assembly checkpoint (SAC), 
monitors whether chromosomes are evenly distributed to daughter cells. During DNA replication, 
replicated sister chromatids are attached to each other by a protein complex called cohesin. Upon 
entering mitosis, the kinetochore, a protein complex located at the centromere of each chromatid, 
binds microtubules extending from opposite poles of the cell. With proper kinetochore-microtubule 
attachment, the multisubunit ubiquitin E3 ligase, anaphase-promoting complex/cyclosome (APC/C) 
associates with a specific coactivator called cell division cycle 20 (CDC20), and ubiquitinates and 
degrades two key proteins maintaining the cell in prometaphase: cyclin B and securin. Cyclin B is a 
regulatory subunit of the master mitotic kinase cyclin-dependent kinase 1 (CDK1) and securin is an 
inhibitor of separase, a cohesin protease. Proteolysis of these proteins leads to the separation of sister 
chromatids (Bolanos-Garcia et al. 2011). However, if a kinetochore is improperly attached to the 
microtubules, multiple SAC factors associate there, forming the mitotic checkpoint complex (MCC), 
which incorporates CDC20 and interferes with APC/C activation, delaying anaphase onset and giving 
the cell time to correct attachment errors. Once proper attachment is achieved, the MCC is dismantled 
and the APC/C is activated, allowing progression to anaphase. Defects in the SAC allow cells with 
improperly attached kinetochores to enter anaphase, generating aneuploid cells. BubR1 (budding 
uninhibited by benzimidazole-related 1) forms the MCC with mitotic arrest deficient-like 1 (Mad2), 
Bub3 and CDC20, and plays a key role in SAC function (Yu 2002).  
BubR1 is a metazoan homologue of yeast (Saccharomyces cerevisiae) Mad3. The general 
domain architecture of BubR1 is shown in Fig 1. Human (Homo sapiens) BubR1 is 1050 residues 
long and can be divided into three regions on both structural and functional grounds: the N-terminal 
region (residues 1–426), containing most of the sequence conserved with yeast Mad3, the C-terminal 
region (residues 730–1050) containing the kinase domain, and a middle region (residues 427–729). 
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Figure 1. Schematic of the structure of BubR1 and Mad3.  
Two Lys-Glu-Asn (KEN) box motifs, three tetratricopeptide repeat (TPR) motifs, and one Gle2 
(nucleoporin)-binding-sequence (GLEBS) motif are located in the conserved region and contribute to 
SAC function. The kinetochore attachment regulatory domain (KARD) and serine/threonine (S/T) 
kinase domain are in the non-conserved region of BubR1. The KARD may promote proper 
kinetochore-microtubule attachments. The function of S/T kinase domain is controversial. H. sapiens, 
Homo sapiens; M. musculus, Mus musculus; X. laevis, Xenopus laevis; D. melanogaster, Drosophila 
melanogaster; S. cerevisiae, Saccharomyces cerevisiae; S. pombe, Schizosaccharomyces pombe, and 
A. thaliana, Arabidopsis thaliana. The residue numbers in each domain of H. sapiens BubR1 and S. 
cerevisiae Mad3 are shown in parentheses below the domain abbreviations. 
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The N-terminal region is the most highly conserved across eukaryotes, and is involved in MCC 
formation and SAC function. The middle region is involved in promoting stable kinetochore and 
microtubule attachments (Karess et al. 2013). The function of serine/threonine (S/T) kinase domain is 
controversial. 
Loss-of-function mutations in Bub1b, which encodes BubR1, cause premature chromatid 
separation (PCS) syndrome (Mendelian Inheritance in Man [MIM] 176430), a congenital disease also 
known as mosaic variegated aneuploidy (MVA) syndrome (MIM 257300) (Hanks et al. 2004, 
Matsuura et al. 2006). PCS/MVA syndrome can be caused by the suppression of Bub1b transcription 
by an intergenic mutation 44-kb upstream of the Bub1b gene (Ochiai et al. 2014). PCS/MVA 
syndrome is diagnosed by the presence of PCS in > 50% of metaphase cells and the presence of 
mosaic aneuploidy. Patients are more prone to develop childhood cancers such as Wilms tumor and 
rhabdomyosarcoma, which may be attributed to loss of SAC function. Obesity, polycystic kidneys, 
postcerebellar cysts, and hypoplasia of the cerebellar vermis are also common clinical findings, but 
the pathophysiological mechanisms of these features are unknown. In recent years, it has been 
postulated that these could be caused by SAC-independent BubR1 functions. 
The primary cilium is a microtubule-based, nonmotile organelle that forms on the surface of 
quiescent mammalian cells (Nigg et al. 2009). It receives extracellular information and transmits 
signals required for cell proliferation, tissue development, and tissue homeostasis. Ciliary dysfunction 
results in human disorders known as ciliopathies (Baker et al. 2009) and affected patients show a 
series of clinical features including polycystic kidneys, polydactyly, obesity, and neuronal and other 
developmental abnormalities, similar to patients with PCS/MVA. Interestingly, impaired ciliogenesis 
was observed in skin fibroblasts from patients with PCS/MVA with mutations in Bub1b (Miyamoto et 
al. 2011), suggesting a link between ciliary dysfunction and loss of BubR1 function. Moreover, 
knockdown medaka fish (Oryzias latipes) displays ciliary dysfunction and typical phenotypes of 
ciliopathies (Miyamoto et al. 2011). These lines of evidence suggest that BubR1 plays an important, 
SAC-independent role in primary cilia formation. 
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BubR1 hypomorphic mice, with approximately 11% of the expression observed in wild type 
mice, show several early aging phenotypes, including short lifespan, cachectic dwarfism, 
lordokyphosis, sarcopenia, cataracts, craniofacial dysmorphisms, arterial stiffening, fat loss, reduced 
stress tolerance, and impaired wound healing (Baker et al. 2004). It was demonstrated that low 
BubR1expression in these mice induces p16Ink4a (a CDK1 inhibitor and marker of senescence) and 
promotes the development of aging-related phenotypes independently of SAC function (Baker et al. 
2008, Baker et al. 2011). Interestingly, BubR1 mRNA and protein levels naturally decrease with 
aging in mice and humans (Baker et al. 2004, Guntani et al. 2011). These findings suggest a role for 
BubR1 in the natural aging process. 
Clearly, BubR1 is a multifunctional protein, and both its SAC-dependent and -independent 
functions are suggested to be related to human disease. Therefore, I hypothesized that elucidating 
further physiological functions of BubR1 might aid in the discovery of new disease mechanisms in 
humans.  
Since decreased BubR1 expression contributes to aging-related phenotypes, I have 
investigated the relationship between BubR1 and impaired liver regeneration due to aging (Chapter 
1). In addition, although numerous reports suggest that high BubR1 expression could be a poor 
prognostic maker for various tumors (Grabsch et al. 2003, Burum-Auensen et al. 2007, Yamamoto et 
al. 2007), and that aneuploidy was observed in these tumors (Pinto et al. 2008, Ando et al. 2010), the 
relationships between these clinical findings and BubR1 expression remain unclear. Thus, I have also 
investigated the contribution of BubR1 to carcinogenesis and tumor malignancy (Chapter 2). Based 
on the results of these studies, I then discuss future directions for functional BubR1 research, and a 
strategy for drug development for BubR1-related diseases.  
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Chapter 1 
BubR1 insufficiency impairs liver regeneration in aged mice after hepatectomy through 
intercalated disc abnormality 
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Introduction 
It was previously demonstrated that decreased BubR1 expression induces cellular 
senescence through p16INK4a up-regulation, and that mutant mice with decreased BubR1 expression 
display various progeroid phenotypes, such as short lifespan, cachectic dwarfism, lordokyphosis, 
cataracts, loss of subcutaneous fat and impaired wound healing (Baker et al. 2004, Matsumoto et al. 
2007, Baker et al. 2008, Baker et al. 2011). Therefore, BubR1 could play an important role in 
regulating aging. Kyuragi et al recently generated a new BubR1 low-expression mouse, which is a 
useful model to investigate the role of BubR1 in response to various kinds of stress because they do 
not display any severe phenotypes during growth and development under normal circumstances 
(Kyuragi et al. 2015). Using this animal model, they have shown that reduced BubR1 expression 
inhibits intimal hyperplasia mediated by reduced vascular smooth muscle cell proliferation after 
carotid artery ligation. 
Adult hepatocytes are normally quiescent cells in the G0 phase of the cell cycle and do not 
undergo cell division, whereas they proliferate to maintain liver homeostasis in response to several 
stimuli, such as surgical resections or liver injury (Fausto 1994, Michalopoulos et al. 1997). After 
partial hepatectomy (PHx), most of the quiescent hepatocytes (95% in young and 75% in old rats) 
rapidly enter the cell cycle (Michalopoulos 2007). In the mouse liver, peak DNA synthesis occurs at 
about 36–44 h after PHx, and DNA synthesis is synchronously initiated in hepatocytes (Matsuo et al. 
2003, Taub 2004, Michalopoulos 2007). When DNA synthesis is impaired, hepatic regeneration is 
also impaired (Rudolph et al. 2000, Satyanarayana et al. 2003). Most of the increase in liver mass 
occurs within 3 days after PHx and the remnant liver regenerates to a size equivalent to the original 
volume within 5–7 days (Grisham 1962).  
In animal models, hepatocytes are directly damaged and thereby induced to undergo 
necrosis or apoptosis to eliminate damaged cells after PHx (Guicciardi et al. 2013). Hepatocyte 
proliferation is initiated by several growth factors or cytokines during liver regeneration that occurs 
after massive hepatocyte necrosis or apoptosis (Fausto et al. 2006). The liver architecture during 
regeneration after PHx is significantly changed, and this change impacts liver function. Intra- and 
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inter-cellular junctions temporarily change during regeneration following PHx and reformation of the 
normal liver architecture occurs only after the original volume is restored. The mechanisms that 
regulate the reorganization of the liver architecture are not well understood (Taub 2004).  
Liver regeneration is series of physio-pathological phenomena that allow recovery of 
damaged tissue and prevent liver failure (Haga et al. 2010). Impairment of liver regeneration is a 
critical problem for aged patients with liver diseases after surgical resection and PHx because their 
liver does not have the ability to regenerate physically and functionally. In the clinical setting, 
impairment of liver regeneration leads to liver dysfunction, which can worsen or affect the patient’s 
general condition and their postoperative prognosis. The operative mortality rate for patients after 
major hepatectomy increased incrementally with age (Fortner et al. 1990). Aging impairs liver 
regeneration and there is a reduced rate of hepatocyte proliferation following resection (Schmucker et 
al. 2011). However, the mechanism of impaired regenerative capacity in the aged liver has not been 
fully elucidated. 
A previous study suggests that BubR1 insufficiency causes early onset of aging-associated 
phenotypes (Baker et al. 2004), but the physiological relevance of BubR1 to liver regeneration and/or 
the effects of BubR1 on liver architecture remain unclear. The purpose of this study is to investigate 
the effects of BubR1 insufficiency on liver regeneration and its architecture using BubR1 low-
expression mice. 
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Materials and Methods 
Experimental animals.   
Animals were maintained under standard conditions and treated according to the Guidelines 
for the Care and Use of Laboratory Animals of Kyushu University. All experimental protocols were 
approved by the Kyushu University Institutional Animal Care and Use Committee. (Approval no. 
A24-220-0). Low-BubR1-expressing mutant (BubR1L/L) and wild-type (WT) littermate control 
(BubR1+/+) mice on a mixed genetic background of C57BL/6J/ and 129/SvJ were generated in the 
laboratory, as previously described. Five-week-old BubR1L/L and BubR1+/+ male mice were used for 
experiments. Young (7-week-old) and aged (53-week-old) C57BL/6JJcl male mice were obtained 
from CLEA Japan Inc. (Tokyo, Japan), and kept in my facility for 2 weeks before use.  
 
Partial hepatectomy model.  
Seventy percent PHx was performed as previously described (Greene et al. 2003, Haga et 
al. 2010). Briefly, the bilateral median lobe and left lateral lobe were ligated and removed. After the 
wounds were sutured, animals were kept on a warming mat to avoid hypothermia. Mice were 
sacrificed to collect the remaining lobes and blood samples at each indicated time point before and 
after PHx. The liver weight-to-body weight ratio (LW/BW) was calculated to estimate liver mass 
recovery. Liver tissue samples were frozen or fixed with formalin and embedded in paraffin. Blood 
samples were collected from the postcava during anesthesia. 
 
Biochemical analyses.  
Asparate:2-oxoglutarate aminotransferase (AST), alanine:2-oxoglutarate aminotransferase 
(ALT), lactate dehydrogenase (LDH), total bilirubin (T-BIL), direct bilirubin (D-BIL), indirect 
bilirubin (I-BIL), total bile acid (TBA), and alkaline phosphatase (ALP) plasma levels were analyzed 
by Nagashima Life Sciences Laboratory (Shiga, Japan). 
 
Cell culture.  
13 
 
A human keratinocyte cell line (HaCaT, Cell Lines Service, Eppelheim, Germany) was 
cultured in Dulbecco’s Modified Eagle’s Medium (DMEM, Thermo Fisher Scientific Inc., Waltham, 
MA, USA), supplemented with 10% heat-inactivated fetal bovine serum (FBS, Sigma-Aldrich Corp, 
St. Louis, MO, USA), 100 U/ml penicillin and 100 µg/ml streptomycin (Thermo Fisher Scientific 
Inc.) in plastic disposable tissue culture flasks for RNA extraction and coverslips for confocal laser 
scanning microscopy at 37°C in a 5% CO2/95% air incubator.  
 
BubR1 knockdown using siRNA.  
Lipofectamine RNAiMAX transfection reagent (Life Technologies, Carlsbad, CA, USA) 
was used to transfect a siRNA targeting BubR1 (sc-37542; Santa Cruz Biotechnology, Dallas, TX, 
USA) or negative control (12935-112; Thermo Fisher Scientific Inc.) into HaCaT cells at a final 
concentration of 5 nmol/L in transfection reagent (dilution, 1:1000; vol/vol), according to the 
manufacturer’s protocol. After siRNA transfection at 24, 48 and 72 h, siRNA-transfected HaCaT cells 
were collected. Total RNA was extracted and reverse-transcription was performed to obtain cDNA. 
BubR1 and desmocollin-1 (DSC1) mRNA expression was evaluated using quantitative real-time 
polymerase chain reaction (qRT-PCR). For confocal laser scanning microscopy, cells were fixed with 
ice-cold methanol after siRNA transfection at 48h.  
 
mRNA quantification using qRT-PCR.  
Total RNA was isolated using ISOGEN (Nippongene, Tokyo, Japan) and cDNAs were 
synthesized from RNAs using SuperScript III First-Strand Synthesis SuperMix (Thermo Fisher 
Scientific Inc.) according to the manufacturer’s instructions. qRT-PCR amplification was performed 
using Applied Biosystems StepOnePlus Real-Time PCR System (Thermo Fisher Scientific Inc.). The 
primer/probe sets for mouse Ccnd1 (Mm00432359_m1), Ccne1 (Mm00432367_m1), Ccna2 
(Mm00438064_m1), Ccnb2 (Mm01171453_m1), p21 (Mm04205640_g1), p16 (Mm00494449_m1) 
and desmocollin-1 (Mm00496525_m1) from the TaqMan gene expression assays (Thermo Fisher 
Scientific Inc.) and the primer/probe set for β-actin (Mm00607939_s1) as a mouse endogenous 
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control were purchased from Thermo Fisher Scientific Inc. The primer/probes sets for human 
desmocollin-1 (Hs00245189_m1) and BubR1 (Hs02758991_g1) from the TaqMan gene expression 
assays (Thermo Fisher Scientific Inc.) and the primer/probe set for glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH, Hs02758991_g1) as a human endogenous control were purchased from 
Applied Biosystems (Haga et al. 2010). Mouse BubR1 expression was analyzed using QuantiFast 
SYBR Green PCR kit (QIAGEN, Tokyo, Japan) and normalized to GAPDH, as previously described 
(Kyuragi et al. 2015). The sequences of primers are as follows: mouse BubR1, 5′-CAG TCC CAG 
CAC AGA CAG TTC CA-3′ (forward) and 5′-GCT AGC GAG CTT CTC TGT GGT TCA-3′ 
(reverse); and GAPDH 5′-ATC TGG AAA GCT GTG GCG-3′ (forward) and 5′-CCA CGA CGG 
ACA CAT TG-3′ (reverse).  
 
Tissue histopathological examination.  
Hematoxylin-eosin (HE) staining and silver impregnation stain were performed on 10% 
formalin-fixed and 3-µm paraffin-embedded sections of liver tissue. For transmission electron 
microscopic observation, liver samples were fixed in glutaraldehyde. Immunostaining was performed 
to detect proliferating cell nuclear antigen (PCNA; M0879, Dako, Tokyo, Japan) and streptavidin–
biotin–peroxidase staining was performed using Histofine SAB-PO (M) immunohistochemical 
staining kit (Nichirei Bioscience Inc., Tokyo, Japan) and counterstained with hematoxylin. At least 
1000 hepatocytes were counted for the mitotic index and PCNA positivity in different sections for 
each group. The necrosis score was calculated by counting the number of necrotic lesions per low-
power magnification (×40) in 8 fields per slide.  
Formalin-fixed/paraffin-embedded tissue specimens were used for immunofluorescence staining. 
Deparaffinization was performed by soaking in xylene for 5 min (twice), 100% ethanol for 3 min, 
95% ethanol for 3 min, 85% ethanol for 3 min, 75% ethanol for 3 min and washing with PBS for 5 
min. The sections were pretreated by autoclaving (121C) for 20 min in 0.01 mol/L citrate-buffered 
saline (pH 6.0) for antigen retrieval. Non-specific reactions were blocked with 10% goat serum 
(Histofine SAB-PO(R) kit, Nichirei Bioscience Inc.) for 10 min. The sections were incubated with 
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rabbit polyclonal antibodies against DSC1 (LS-C167539, 1:50; LifeSpan BioSciences, Seattle, WA, 
USA) at 4C overnight, before washing with PBS. The sections were incubated with anti-rabbit 
immunofluorescence antibodies (Alexa Fluor 555, 1:200, Abcam) to detect DSC1 for 60 min and 
washed 3 times with PBS for 5 min each.  
 
Confocal Laser Scanning Microscopy.  
siRNA mediated HaCaT cells were rinsed in PBS at 37 °C, fixed in cold methanol for 3 min 
at −20 °C, blocked (PBS containing 2% BSA and 2% normal goat serum) for 30 min at room 
temperature, and incubated with the following antibodies at the indicated dilution: rat anti-DSC1 at 
1:100 (MAB7367; R&D Systems, Inc., Minneapolis, MN USA), rabbit anti-BubR1 at 1:100 (612503; 
BD Biosciences, San Jose, CA). Cells were rinsed in PBS at 37 °C, fixed in 4% paraformaldehyde for 
15 min at 37 °C, permeabilized (PBS containing 0.2% Triton X-100) for 5 min at room temperature, 
blocked (PBS containing 2% BSA and 2% normal goat serum) for 30 min at room temperature. 
Secondary antibodies conjugated to Alexa Fluor 488, 555 (Molecular Probes) were used at 1:2,000 
dilution. After a wash in PBS containing 4,6-diamidino-2-phenylindole (DAPI) for 5 min, the 
coverslips were mounted in ProLong Gold (Thermo Fisher). Fluorescence image acquisition was 
performed using a Nikon A1R confocal imaging system controlled by the Nikon NIS Elements 
software (Nikon). The objective lens was an oil immersion Plan-Apo × 60 numerical aperture (NA) 
1.40 lens (Nikon). Images were acquired as Z-stacks at 0.2-μm intervals and maximum-intensity 
projections were generated using the NIS Elements software (Nikon).  
 
Western blot analysis.  
Western blot analysis was performed as previously described (Liu et al. 2012). Livers were 
isolated and all surrounding material was removed. After preparing lysates, proteins were separated 
using SDS-PAGE and transferred to a nylon membrane. The blots were probed with primary antibody 
for DSC1 (LS-C 167539, 1:500, LifeSpan BioSciences). Equal loading was confirmed using β-actin 
16 
 
(#4970, 1:1000, Cell Signaling Technology Inc.). Results are representative of three independent 
animals of each genotype at each age. 
 
Enzyme-linked immunosorbent assay for hepatocyte growth factor.  
Frozen liver tissue was homogenized in lysis buffer (CelLytic MT Cell Lysis Reagent, 
Sigma Aldrich, St. Louis, MO, USA) containing protease inhibitor cocktail (Nacalai Tesque, Kyoto, 
Japan) and hepatic hepatocyte growth factor (HGF) levels were measured using the Mouse/Rat HGF 
Quantikine ELISA Kit (R&D Systems, Minneapolis, MN, US). HGF levels were normalized to total 
protein levels in the liver tissue, as measured using a Bio-Rad Protein Assay (Bio-Rad, Hercules, CA, 
USA). 
 
Statistical analysis.  
Data were presented as the mean±standard deviation (SD). The Student’s t-test was 
performed using JMP pro (version 9.0.0, SAS Institute Inc., Cary, NC, USA). Additional professional 
statistical assistance was provided by Junji Kishimoto, Kyushu University. Differences were 
considered to be significant at p<0.05. 
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Results 
BubR1 mRNA expression in liver regeneration after partial hepatectomy.  
BubR1 mRNA expression levels in the liver are shown in Fig. 2A, B and C. In BubR1L/L 
mice, BubR1 mRNA expression was significantly lower (0.11±0.09, p<0.01) than that of BubR1+/+ 
mice (1.00±0.67; Fig. 2A). BubR1 expression (0.62±0.26, p<0.05) was significantly decreased in 
aged mice compared with young mice (1.00±0.26; Fig. 2B). Fig. 2C revealed an alteration of BubR1 
mRNA expression after PHx in BubR1L/L mice and BubR1+/+ mice. In BubR1+/+ mice, BubR1 mRNA 
expression was significantly increased after PHx and reached a maximum level 48 h after PHx 
(18.55±6.92). In BubR1L/L mice, the expression level was low, similar to that observed in untreated 
BubR1L/L mice. In addition, BubR1 expression was delayed in BubR1L/L mice. 
The LW/BW was compared in BubR1+/+ and BubR1L/L mice (Fig. 2D), and in young and 
aged mice (Fig. 2E). In all groups, LW/BW was significantly decreased 12 h after PHx. LW/BW was 
significantly lower in BubR1L/L mice (0.025±0.006, p<0.05) compared with BubR1 +/+ mice 
(0.034±0.006) 48 h after PHx (Fig. 2D), and significantly lower in aged mice (0.033±0.002, p<0.05) 
compared with young mice (0.037±0.001) 144 h after PHx (Fig. 2E). The delay in liver regeneration 
did not cause significant change in mortality between BubR1+/+ and BubR1L/L mice at any time point 
after PHx.  
 
Biochemical analysis during liver regeneration.  
 Tables 1 and 2 show serial changes in laboratory data of mice with PHx. Plasma AST, ALT 
and LDH levels were dramatically increased 12 h after PHx in BubR1L/L and BubR1+/+ mice, and these 
values were significantly higher in BubR1L/L mice than in BubR1+/+ mice 12‒24h after PHx (Table 1). 
In addition, plasma T-BIL, D-BIL, I-BIL, TBA and ALP levels were significantly higher in BubR1L/L 
mice 24 h after PHx. These data indicate that, in BubR1L/L mice, impaired liver function continues for 
a longer period compared with BubR1+/+ mice. The effect of aging on liver dysfunction after PHx was 
also examined, and levels of plasma AST, ALT and LDH 24‒48 h after PHx were significantly 
greater in aged mice than those in young mice (Table 2).  
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BubR1 insufficiency caused an abnormal cell-cycle progression in hepatocyte after partial 
hepatectomy.  
To investigate the underlying mechanisms of impaired liver regeneration in BubR1L/L mice, 
I examined alterations of proliferation markers after PHx (Fig. 3A, B). In BubR1+/+ mice, the number 
of PCNA-positive hepatocytes (185.7±63.5 vs. 1.69±2.16, p<0.01) and those undergoing mitosis 
(16.9±10.7 vs. 2.59±5.80, p<0.05) significantly increased 48 h after PHx compared with those 12 h 
after PHx. Such increases of both values were not observed in BubR1L/L mice (PCNA, 54.3±56.7; 
mitosis, 2.0±2.9). Fig. 3C shows the representative liver sections at 12, 24, 48, 96, 144 hours after 
PHx stained for PCNA in BubR1L/L and BubR1+/+ mice. The peak of hepatocyte proliferation is 
observed 48 h after PHx in normal mice (Lehmann et al. 2012). Slow progression of hepatocyte 
proliferation was evident in BubR1L/L mice 48 h after PHx and thereafter.  
Based on reduced hepatocyte proliferation, I also investigated cyclin-D, cyclin-E, cyclin-A 
and cyclin-B mRNA expression levels (Fig. 3D). In BubR1L/L mice, cyclin-D (0.93±0.44, p<0.05), 
cyclin-A (0.23±0.07, p<0.01) and cyclin-B (0.10±0.05, p<0.01) mRNA expression levels were 
significantly lower compared with those of BubR1+/+ mice (1.71±0.47, 0.87±0.27 and 0.32±0.13, 
respectively) 12 h after PHx. The expression patterns of cyclin-D in BubR1+/+ and BubR1L/L mice were 
different: two peaks at 12 and 48 h after PHx were observed in BubR1+/+ mice while a single but 
broader peak was observed in BubR1L/L mice. In BubR1+/+ mice, cyclin-A and cyclin-B mRNA 
expression showed remarkable increases 48 h after PHx, and rapidly decreases 96 h after PHx. 
Cyclin-B mRNA expression was significantly attenuated in BubR1L/L mice (5.6±4.6, p<0.05) 
compared with BubR1+/+ mice (21.3±12.5) 48 h after PHx. These low expression levels continued up 
to 144 h after PHx without a rapid decrease. Similar patterns were observed in the expression of 
cyclin-A. Cyclin-E mRNA expression was significantly higher in BubR1L/L mice (1.4±0.4, p<0.05) 
compared with BubR1+/+ mice (0.8±0.4) 24 h after PHx.  
I also examined the expression of a CDK inhibitor, p21 (Fig. 3E). In BubR1L/L mice, p21 
mRNA expression (3.51±1.51, p<0.05) was significantly higher than that in BubR1+/+ mice 
(1.74±0.76) 24 h after PHx. I also examined the mRNA expression of p16INK4a, another CDK 
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inhibitor, because it is reported that down-regulation of BubR1 causes up-regulation of p16 INK4a 
expression and induces cellular senescence (Baker et al. 2008, Baker et al. 2011). In my study, 
however, p16 INK4a mRNA expression was too low to detect in mice (data not shown). Moreover, I 
analyzed levels of HGF that is known to play an important role in driving liver regeneration 
(Michalopoulos 2007). There was no significant difference in the level of liver HGF between 
BubR1+/+ and BubR1L/L mice (Fig. 3F). 
BubR1 insufficiency increases hepatocyte necrosis accompanied with intercalated disc 
abnormality.  
There were no detectable differences in liver histology between intact BubR1+/+ and 
BubR1L/L mice (data not shown). In BubR1L/L mice, focal hepatic necrosis was observed 12‒96 h after 
PHx and the number of necrotic foci in the liver tissue of BubR1L/L mice (2.95±1.11, p<0.01) was 
significantly higher than in the BubR1+/+ mice (0.23±0.61; Fig. 4A) at 24 h after PHx. Also the 
necrosis area in BubR1L/L mice (0.016±0.005, p<0.05) was significantly larger than in the BubR1+/+ 
mice (0.010±0.004; Fig. 4B) at 24 h after PHx. The necrosis area in BubR1L/L mice showed a 
maximum at 24 hours and then gradually decreased. The necrotic foci scattered in liver lobule and it 
was characterized by necrotic hepatocytes and dilation of perisinusoidal spaces with hemorrhage (Fig. 
4C, D).  
Fig. 4E shows transmission electron microphotographs of hepatic tissue obtained from 
BubR1+/+ (panels a1 and a2) and BubR1L/L mice (panels b1 and b2) 12 h after PHx. Compared with 
BubR1+/+ mice, BubR1L/L mice showed wider intercellular spaces. Observation at higher 
magnification revealed a wider perisinusoidal space containing atrophic microvilli and dispatched 
intercalated disks (IDs) (white arrows) in the hepatic tissue of BubR1L/L mice (panel b2). In addition, 
hepatocyte mitochondria were severely swollen and electron-lucent. In BubR1L/L mice 12 h after PHx, 
the number of damaged hepatocytes was higher than in BubR1+/+ mice, and these features were not 
observed in BubR1L/L mice without PHx (data not shown). These histopathological findings suggest 
that in BubR1L/L mice, abnormal structural intercellular alterations are accompanied by hepatocyte 
necrosis after PHx. 
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Effects of low BubR1 expression on desmocollin-1 expression.  
To investigate a possible mechanism of liver injury and impaired liver regeneration, I 
studied the effect of low BubR1 expression on desmocollin-1 (DSC1) expression in mouse liver tissue 
and HaCaT cells. Immunohistochemical examination revealed that DSC1 expression in the liver was 
attenuated after PHx in BubR1 L/L mice compared with Bub1R+/+ mice (Fig. 5A). Western blot analysis 
of the liver extracts also revealed that in BubR1L/L mice, DSC1 protein expression (0.36±0.18, p<0.05) 
was significantly decreased 24 h after PHx compared with BubR1+/+ mice (0.78±0.26) (Fig. 5B). I 
then examined the effect of BubR1 siRNA on DSC1 expression in HaCaT cells. BubR1 expression 
was significantly decreased 24 and 48 h after transfection (siRNA(+) vs. siRNA(−) at 24 h; 0.21±0.03 
vs. 1.00±0.19, p<0.01, and at 48 h; 0.16±0.05 vs. 0.89±0.25, p<0.01; Fig. 6A). DSC1 mRNA 
expression was also attenuated and significantly inhibited 48 h after transfection (siRNA(+) vs. 
siRNA(−); 1.19±0.39 vs. 3.16±0.89, p<0.01; Fig. 6B). These results suggest that BubR1 regulates 
DSC1 expression in hepatocytes. To demonstrate the effect of BubR1on junctional formation in 
HaCaT cells treated with and without BubR1 siRNA, I performed confocal laser scanning microscopy 
analysis using combined BubR1/desmocollin-1/DNA staining. Fig. 6C shows confocal laser 
microphotographs of HaCaT cells treated with control siRNA (panels a1, a2, a3, and a4 ) and BubR1 
siRNA (panels b1,b2,b3, and b4) 48 h after BubR1 siRNA. Panels a2 and a3 show positive correlation 
between expression of BubR1 and DSC1. White arrows indicate high expression of BubR1 and DSC1 
(panels a2, a3, and a4) in parallel. Yellow arrows indicate low expression of BubR1 and DSC1 
(panels a2, a3, a4, b2, b3, and b4) in parallel. Compared with control siRNA (panel a3), BubR1 
siRNA (panel b3) showed small number of red dots structure which indicate desmosome junction 
between cells (orange arrows). These confocal laser scanning microscopy findings suggest that 
BubR1 expression could correlate with DSC1 expression and affect desmosome junctional formation. 
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Figure 2. Alterations in BubR1 mRNA expression and liver weight (LW)/body weight (BW) ratio. 
 
(A) BubR1 mRNA expression in intact BubR1+/+ (□) and BubR1L/L (■) mice. (B) BubR1 mRNA 
expression in intact 9-week-old (  ) and 55-week-old (  ) C57BL/6JJcl mice. (C) Changes in BubR1 
mRNA expression in BubR1+/+ (□) and BubR1L/L (■) mice after PHx. Relative expression level to 
unhepatectomized BubR1+/+ mice is shown. (D) Changes in LW/BW in BubR1+/+ (□) and BubR1L/L 
(■) mice after PHx. (E) Changes in LW/BW in 9-week-old (  ) and 55-week-old (  ) C57BL/6JJcl 
mice. Data are presented as the mean ± S.D. †p<0.05, ††p<0.01 vs. intact mouse in each group. 
*p<0.05, ** p<0.01 vs. BubR1+/+ mice at each sampling point. 
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24 
 
Figure 3. Changes in proliferation markers after PHx. 
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(A) PCNA-positive cells, (B) cells undergoing mitosis. (C) Representative liver sections at 12, 24, 48, 
96, 144 hours after PHx stained for PCNA. (magnification ×200): arrowhead, cells undergoing 
mitosis. (D) cyclin D, cyclin E, cyclin A and cyclin B mRNA expression, (E) p21 mRNA expression, 
(F) HGF level in BubR1+/+ (□); BubR1L/L (■); data are presented as the mean ± S.D. †p<0.05, 
††p<0.01 vs. intact mouse in each group. *p<0.05, ** p<0.01 vs. BubR1+/+ mice at each sampling 
point.  
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Figure 4. Histopathological data.  
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(A) Necrosis score and (B) necrosis area after PHx: BubR1+/+ (□); BubR1L/L (■); data are expressed 
as the mean ± S.D. †p<0.05, ††p<0.01 vs. 12 h after PHx. **p<0.01 vs. BubR1+/+ mice at each 
sampling point. (C) Representative altered liver histopathology at 24 h after PHx with HE staining 
(magnification ×40): arrowhead, necrosis foci. Scale bars: 500 µm (D) Representative necrosis foci 
histopathology at 24 h after PHx in BubR1L/L mice: Left, HE staining; right, silver impregnation 
(magnification ×400); arrow, necrotic hepatocytes; arrowhead, dilation of perisinusoidal spaces with 
hemorrhages. (E) Transmission electron microphotographs of hepatic tissue obtained from BubR1+/+ 
(panels a1 and a2) and BubR1L/L (panels b1 and b2) mice 12 h after PHx. Compared with BubR1+/+ 
mice, BubR1L/L mice displayed a wider intercellular space. Observation at higher magnification 
revealed a wider perisinusoidal space containing atrophic microvilli and dispatched intercalated discs 
(white arrows) in the hepatic tissue of BubR1L/L mice (panel b2). In addition, hepatocyte mitochondria 
were severely swollen and electron-lucent. Nucl, nucleus; MV, microvilli; Mt, mitochondria; white 
arrows, intercalated disc. Scale bars: 5 µm in panels a1 and b1; 1 µm in panels a2 and b2 
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Figure 5. DSC1 expression in hepatocytes after PHx.  
(A) Immunohistochemical staining of DSC1: red staining indicates DSC1 at the intercalated disc. (B) 
Western blotting data of DSC1: upper panel shows representative data for DSC1; BubR1+/+ (□); 
BubR1L/L (■); data are mean ± S.D. **p<0.01 vs. BubR1+/+ mice at each sampling point. 
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Figure 6. Effect of BubR1 siRNA on DSC1 expression in HaCaT3 cells.  
(A) Expression of BubR1 and (B) DSC1 mRNA after BubR1 siRNA transfection; control siRNA 
(□); BubR1 siRNA (■); data are mean ± S.D. **p<0.01 vs. control siRNA at each sampling point. 
(C) BubR1 siRNA reduced DSC1 expression and disarrayed HaCaT cells.  
Control (panel a1, a2, a3, and a4) and BubR1 siRNA mediated (panel b1, b2, b3, and b4) HaCaT cells 
were stained using BubR1 (green)- and DSC1-specific antibodies (red) and analyzed by conforcal 
laser scanning microscopy. DNA was visualized by DAPI staining (blue). Representative 
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experimental results are shown. White arrows indicate high expression of BubR1 and DSC1. Yellow 
arrows indicate low expression of BubR1 and DSC1. Compared with control siRNA (panel a3), 
BubR1 siRNA (panel b3) showed small number of red dots structure which indicate desmosome 
junction between cells (orange arrows).  
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Discussion 
Aging delays liver regeneration after hepatectomy leading to postoperative liver failure and 
worsening general condition, which critically affect the patient’s prognosis. Although this 
phenomenon was reported over 50 years ago, the molecular mechanism for the loss of regenerative 
capacity in aged livers has not been fully elucidated (Timchenko 2009).  
Novel findings in this study are summarized as follows: (1) BubR1 insufficiency delays 
liver regeneration after PHx possibly because of transient impairment of G1-S cell cycle progression; 
(2) microscopic observation of BubR1L/L mice liver shows increased necrotic hepatocytes. 
Transmission electron microphotographs of hepatic tissue also show increased necrotic hepatocytes 
accompanied by intercalated disc (ID) abnormality; and (3) I demonstrated, for the first time, that 
BubR1 controls expression of DSC1, a transmembrane cell adhesion protein in desmosomes. The 
increase in levels of DSC1, which is expressed in the desmosome, was suppressed in BubR1L/L mice 
liver after PHx. In addition, down-regulation of BubR1 expression with siRNA reduced DSC1 
expression in HaCaT cells. These findings provide evidence for a possible molecular mechanism by 
which aging impairs liver regeneration after hepatectomy. 
BubR1 is a key molecule in the spindle assembly checkpoint during mitosis (Yu 2002). 
Previous studies demonstrated that BubR1 insufficiency in mice caused phenotypic changes that are 
similar to those found in aging mice (Baker et al. 2004, Matsumoto et al. 2007, Baker et al. 2008, 
Baker et al. 2011). At the early stage (48 h after PHx) of the liver regeneration, BubR1 mRNA 
expression was significantly increased in WT mice (BubR1+/+), suggesting that BubR1 is an important 
molecule involved in this process. Regeneration assessed by the increased LW/BW after PHx 
indicates impaired liver regeneration in BubR1L/L mice. Aged WT mice also showed impaired liver 
regeneration, and I observed that BubR1 expression in intact liver significantly decreased in aged 
mice compared with young mice. These observations indicate that transient delayed liver regeneration 
after hepatectomy is associated with reduced BubR1 expression and other factor such as EGF and 
FoxM1B may affect sustained delayed liver regeneration in aged mice (Schmucker et al. 2011). It was 
previously observed in the senescent liver that activity of ALT, AST, and all types of bilirubin was 
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increased in the blood of partially hepatectomized aged mice as a result of liver dysfunction 
(Schmucker 2005). The reduced BubR1 expression level itself did not affect circulating hepatic 
enzyme levels or liver weight and morphology in untreated BubR1L/L mice (data not shown), ruling 
out the possibility that the reduction of BubR1 expression contributes to alterations of liver function 
and size in BubR1L/L mice (Fig. 1D, Table 1). Thus, my results suggest that age-related inhibition of 
liver regeneration may be attributed to the reduction in BubR1 expression (Haga et al. 2010, Gregg et 
al. 2012, Sanchez-Hidalgo et al. 2012).  
Hepatocytes are normally quiescent cells. The initiation of hepatocyte proliferation or liver 
regeneration after hepatectomy requires activation of the mitogenic genes and repression of genes 
responsible for inhibiting hepatocyte proliferation (Su et al. 2002). Fewer hepatocytes in older 
animals and humans enter the S-phase after partial hepatectomy compared with younger subjects 
(Schmucker et al. 2011). In mice, a sharp peak of hepatocyte proliferation is usually observed at 48 h 
post-PHx (Lehmann et al. 2012), but such steep increase and decrease were not observed in BubR1L/L 
mice. Instead, a few cells initiated proliferation and mitosis 48 h after PHx, and continued to 
proliferate up to 144 h. These findings suggest that hepatocyte proliferation after PHx was delayed in 
BubR1L/L mice. As a result, delayed cyclin gene expression was observed in hepatectomized BubR1L/L 
mice. Comparison of cyclin-D expression patterns in BubR1+/+ and BubR1L/L mice revealed an 
apparent delay in cyclin-D induction after PHx in BubR1L/L mice. Increasing of cyclin-D and –E 
expression accelerate the G1/S phase transition (Resnitzky et al. 1994). At 24 h after PHx, cyclin-D 
and –E expression levels in BubR1L/L mice were higher than in BubR1+/+ mice, it suggested that G1/S 
phase cells accumulated in Bub1b L/L mice. Cyclin-A and -B expression levels increase in late S phase 
and peak in G2 of normal cells (Muschel et al. 1993). While cyclin-A and -B peak expression levels 
were observed at 48 h after PHx in BubR1+/+ mice, moderate cyclin-A and -B expression was induced 
at 48 h after PHx in BubR1L/L mice, and remained constant up to 144 h. These patterns were the same 
as those of the mitotic and PCNA-positive indices hepatocytes in hepatectomized BubR1L/L mice. 
These results suggested that fewer proliferating hepatocytes may result from a delay in cell cycle 
progression in BubR1L/L mouse hepatocytes. I also found that p21 expression was higher in BubR1L/L 
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than BubR1+/+ mice at 24 h post-PHx. p21 is a CDK inhibitor that hampers the activity of cyclin-
E/CDK2 and cyclin-D/CDK4/6 complexes (Wang et al. 2002). Therefore, my results suggest that 
arrest and/or delay of cell cycle progression from G1 to S phase occurred in hepatocytes in the 
partially hepatectomized BubR1L/L mice. Several studies demonstrate that p21 plays a key role during 
liver regeneration, such as in the acute liver injury model (Hui et al. 2002) and in the extended 
hepatectomy model (Lehmann et al. 2012). Moreover there was no difference in the HGF protein 
content between BubR1+/+ mice and BubR1L/L mice, it suggested that both mice had received the 
equivalent to the stimulation of cell proliferation. Therefore these studies demonstrated up-regulation 
of p21 accompanied by a delay in cell cycle progression, which is consistent with my results in 
BubR1L/L mice.  
Microscopic observation revealed that after PHx, necrosis but not apoptosis of hepatocytes 
was strongly induced in BubR1L/L mice compared with BubR1+/+ mice. These observations were 
consistent with a biochemical analysis of blood in BubR1L/L mice. The activities of ALT, AST and all 
types of bilirubin were increased in partially hepatectomized BubR1L/L mice. Such increases are 
observed in the clinical condition when liver regeneration is impaired in the patients after PHx. In the 
regenerating liver, epithelial cells require physical contact with extracellular matrix to avoid the 
detachment induced cell death (DICD) of hepatocytes. After PHx, the reconstitution of a 
perisinusoidal extracellular matrix stabilizes the newly formed hepatocyte population. Thus, necrosis 
that is observed in partially hepatectomized BubR1L/L mice might be the result of excessive DICD 
caused by failure of perisinusoidal extracellular matrix reconstitution.  
Morphological analysis of livers from BubR1L/L mice demonstrated a widened 
interhepatocyte space, shrinking hepatocytes, a widened perisinusoidal space and atrophy of 
microvilli in the early stages after PHx, suggesting that partial microstructure failure results from a 
weak adaptation to changed microcirculatory flow by PHx in BubR1L/L mice. Hepatocytes connect via 
intercellular junctions called IDs to form liver cell plates. IDs are composed of different types of 
junctional complexes, including gap-junctions made of connexins, tight- and adherens-junctions, and 
desmosomes. Desmosomes are button-like structures composed of intracellular anchor proteins and 
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transmembrane adhesion proteins. The intracellular anchor proteins play a role in connecting the 
cytoskeleton to the transmembrane adhesion proteins including desmocollin, a member of the 
cadherin family. Desmosomes maintain the integrity of cells to resist mechanical stress, and have 
dynamic structures whose adhesiveness can switch between high and low affinity adhesive states 
during cell division, thereby participating in fundamental processes such as cell proliferation, 
differentiation and morphogenesis (Garrod et al. 2008). Thus, it is possible that the weakened cell 
attachment observed in the hepatectomized BubR1L/L mice could be caused by desmosome 
abnormality. There are multiple components to hepatocyte junctions. I evaluated expression of 
occludin located at the tight junctions, E-cadherin located at the adherent junctions, DSC1 and 
desmoglein in mouse liver. Expression of occludin, E-cadherin, and desmoglein was not so 
remarkably different between BubR1L/L mice and BubR1+/+ mice by immunohistochemistry (data not 
shown).  Expression of desmocollin-1 was remarkably different in control cells compared with 
BubR1 reduced cells in vitro and in mouse liver. DSC1, a desmosome transmembrane cell adhesion 
protein, is highly expressed in the liver (Donetti et al. 2004). I showed that up-regulation of DSC1 
expression after PHx was not observed in BubR1L/L mice. I also demonstrated that small interfering 
RNA-mediated down-regulation of BubR1 suppressed DSC1 expression in HaCaT cells which is well 
known that both mRNA and protein are abundant. These results suggest that BubR1 could be a 
critical regulating factor for DSC1 expression. My hypothesis is that DSC1 could be a target protein 
which is ubiquitinated by APC/C for the degradation by the proteasome. To investigate this 
hypothesis, I examined the DSC1 protein expression under APC/C inhibitor by Western blot. Western 
blot showed that APC/C inhibitor upregulated the DSC1 expression same as securin with which 
BubR1 directly interacts in vitro and in vivo (manuscript in preparation). My speculation is that DSC1 
is one of the proteins that are ubiquitinated by APC/C and, thus may be one of the targets of BubR1. 
However, to further explore the relationship between a cell cycle checkpoint protein and a junctional 
protein are needed. The reduced DSC1 level could cause abnormal cell attachment and delay liver 
regeneration in BubR1L/L mice.  
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Based on these findings, I propose a possible scenario that occurs after PHx in aged 
individuals. Hepatectomy induces many stresses, including physical stress and cell division-associated 
stress. After hepatic resection, portal hypertension occurs because the vascular network in the remnant 
lobes is reduced despite constant blood flow from the portal vein (Bosch et al. 1992). The liver cells 
and liver sinusoidal endothelial cell attachment are affected by these stresses during liver regeneration 
after hepatectomy (Sato et al. 1997), leading to transient DICD and G1 arrest to prevent an excessive 
DICDs. DSC1 expression also increases, thus leading to reinforcement of desmosomes to maintain 
cell attachments, which is an important process to prevent massive DICD and anokisis, and thus focal 
necrosis of hepatocytes. In the case of low BubR1 expression, the increased level of DSC1 expression 
is not enough to reinforce the desmosome after PHx, leading to increased DICD and anokisis, and 
thus resulting in hepatocyte focal necrosis. Impairment of cell attachment induces DICD and G1 
arrest in a p21-dependent manner (Collins et al. 2005). Therefore, the delayed G1/S progression 
occurs through up-regulation of p21 caused by secondary effects from the failure of DICD 
reinforcement because of a DSC1 abnormality, rather than via a direct effect of low BubR1 level. 
Thus, delayed liver regeneration could occur after PHx in aged patients.  
In summary, BubR1 insufficiency causes delayed liver regeneration after partial 
hepatectomy. BubR1 expression is reduced along with aging. BubR1 insufficiency reduces DSC1 
expression in the liver, and thus weakens the microstructural adaptation of the tissue against 
hepatectomy. BubR1 insufficiency, thus, enhances transient liver failure and injury through the cell 
cycle delay caused by up-regulation of p21 that results from the weakened microstructural adaptation. 
Therefore, hepatocyte proliferation is delayed and liver regeneration could be impaired. This work 
provides new insights into the role of BubR1 in liver regeneration, which may explain worsening liver 
function after hepatectomy in aged patients. 
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Chapter 2 
Contribution of BubR1 to oxidative stress-induced aneuploidy in p53 deficient cells 
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Introduction 
In 1891, von Hansemann et al. have first observed a numerical chromosome aberration, 
DNA aneuploidy, in malignant tumors (Hansemann 1891). Previous studies have revealed that 
significant parts of tumors exhibit DNA aneuploidy and tumors with DNA aneuploidy are 
significantly correlated with poor cancer prognosis (Cimini 2008). Although extensive efforts have 
been made to unveil the mechanism causing DNA aneuploidy, it is still not totally understood.   
 The appropriate expression of spindle assembly checkpoint (SAC) factors may be one 
important factor to maintain chromosome stability. SAC is a surveillance system controlling the 
segregation of sister chromatids to daughter cells in mitosis (Musacchio et al. 2007). Overexpression 
or downregulation of SAC factors may cause an aberrant SAC function, an unequal segregation of 
chromosomes and DNA aneuploidy (Michel et al. 2001, Wang et al. 2004, Baker et al. 2006, Sotillo 
et al. 2007, Ando et al. 2010). Consistently, DNA aneuploidy is often found in various tumors with 
abnormal expression of SAC factors (Perez de Castro et al. 2007).  
The p53 signaling pathway is a major suppressor of chromosome instability (Aylon et al. 
2011). The p53 controls the transcription of cell cycle checkpoint factors, such as p21, and regulates 
cell cycle progression at G1-S or G2-M transitions (Levine 1997). The p53 also regulates BubR1 and 
Mad2 expression and suppresses centrosome amplification (Oikawa et al. 2005, Schvartzman et al. 
2011) or aneuploidy. The correlation between abnormal p53 status and DNA aneuploidy has been 
observed in various human tumors (Ando et al. 2010, Kudela et al. 2012). 
  Aerobic metabolism, with its advantages of high levels of energy production, is essential for 
all the organisms exposed to oxidative stress (OS). However, OS causes DNA damage, and is an 
indirect cause of mutations, gene deletions, and chromosome instability that may lead to malignant 
transformation. OS is also suggested to contribute to an increase in aneuploid cells (Gorla et al. 2001, 
Roh et al. 2012). However, how the p53 signaling pathway activated by OS suppresses aneuploidy is 
not fully understood. In this study, I found that BubR1 and Mad2 are downregulated by OS in p53-
dependent manner. When p53 expression was suppressed by siRNA, the BubR1 and Mad2 
downregulation by OS was not observed and polyploid cells increased. Importantly, BubR1, but not 
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Mad2, downregulation suppressed OS-induced polyploidization in p53 knocked down cells, 
suggesting that BubR1 could have novel function other than SAC to contribute to polyploidization. 
Moreover, from the analysis of clinical gastric cancer specimens, I found that tumor with positive 
staining of p53 and high expression of BubR1 tended to exhibit aneuploidy. These findings could 
provide one possible model for underlying mechanism for gastric carcinogenesis associated with 
DNA aneuploidy.   
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Materials and Methods 
Reagents and antibodies 
Potassium bromate (KBrO3) was purchased from Sigma-Aldrich (Gillingham, UK). The 
following antibodies were used: a rabbit polyclonal anti-phospho (ser15) p53 antibody (Cell Signaling 
Technology, Beverly, MA), a mouse monoclonal anti-p53 antibody (DAKO, Dako Cytomation, 
Glostrup, Denmark), a mouse monoclonal anti-p21 antibody (DAKO, Dako Cytomation, Glostrup, 
Denmark), a mouse monoclonal anti-BubR1 antibody (Clone 9, BD Transduction Laboratories, San 
Jose, CA, USA), a mouse monoclonal anti-Mad2 antibody (ImmuQuest, Cleveland, UK), a mouse 
monoclonal anti-β-actin antibody (Sigma Aldrich, St. Louis, MO, USA), a mouse monoclonal anti-
Lamin A/C antibody (Cell Signaling Technology, Beverly, MA), a rat monoclonal anti--tubulin 
antibody (Abcam, Cambridge, UK), an Alexa594-conjugated goat anti-rat IgG antibody and an 
Alexa488-conjugated goat anti-mouse IgG antibody (Invitrogen, Carlsbad, CA). 
 
Cell culture 
Human fibroblasts cells (MRC5) and gastric cancer cells (SNU-1, KATOⅢ) were obtained 
from ATCC (Manassas, VA, USA). Gastric cancer cells (MKN-45 and MKN-28) were obtained from 
Riken Cell Bank (Tsukuba, Japan). MRC5 cells were cultured in Eagle’s Minimum Essential Medium 
supplemented with fetal bovine serum (10% v/v), at 37 °C in a 5% CO2 environment. In my 
experiments, I used MRC5 cells collected between passages 5 and 8. KATOⅢ, MKN-45 and MKN-
28 cells were cultures in Roswell Park Memorial Institute 1640 medium supplemented with fetal 
bovine serum (10% v/v), at 37 °C in a 5% CO2 environment. 
 
Western blotting 
Cells in the logarithmic growth phase were lysed in lysis buffer (0.5 % NP-40, 20 mM Tris–
HCl, pH 8.0, 150 mM NaCl, 1 mM EDTA, and 1 % protease inhibitor cocktail (Nacalai Tesque, Inc., 
Kyoto, Japan). The protein content was determined using Bradford assay (Bio-Rad, Hercules, CA, 
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USA). The same amount of protein (8 g) was loaded on each lane. The immunoreactive bands were 
detected using the LAS3000 system (GE healthcare, Tokyo, Japan). 
 
Quantification of mRNA in fibroblast cells using real-time PCR  
Total RNA was isolated using ISOGEN (Nippongene, Tokyo, Japan) and cDNAs were 
synthesized from RNAs using SuperScript™ III First-Strand Synthesis SuperMix (Invitrogen, 
Carlsbad, CA) according to manufacturer’s instructions. Quantitative PCR amplification was 
performed using Applied Biosystems StepOnePlus™ real-time PCR system (Life Technologies, 
Tokyo, Japan) and a QuantiFast™ SYBR® Green PCR kit (QIAGEN, Hilden, Germany). The BubR1 
and Mad2 transcript levels were determined using β-actin as an endogenous control. The 
oligodeoxynucleotide primers were as follows: BubR1, 5′-CTCGTGGCAATACAGCTTCA-3′ 
(forward) and 5′-CTGGTCAATAGCTCGGCTTC-3′ (reverse)(Ando et al. 2010), Mad2, 5′- 
ACTTAAATATCTCCCTACCTATACTGAGTCAA-3′ (forward) and 5′-
TAGTAACTGTAGATGGAAAAACTTGTGCTA-3′ (reverse) (Bottone et al. 2003) and -actin, 5′-
CCACGAAACTACCTTCAAC--3′ (forward) and 5′-GATCTTCATTGTGCTGGG-3′ (reverse)(Ando 
et al. 2010). 
 
Small interfering RNA transfection  
MRC5 cells were transfected with 10 nmol/L small interfering RNA (siRNA) 
oligonucleotides using Lipofectamine RNAiMAX Reagent (Invitrogen) according to the 
manufacturer’s instructions. The following siRNA were used: p53 (5′-
GAAAUUUGCGUGUGGAGUA-3′ ON-TARGETplus human TP53 siRNA, Dharmacon), BubR1 
(5′-AAGGGAAGCCGAGCUGUUGAC-3′) (Dai et al. 2004) and Mad2 (SMARTpool: ON-
TARGETplus MAD2L1 siRNA, Dharmacon). The ON-TARGETplus Non-targeting Pool 
(Dharmacon) was used as control. Cells were lysed for Western blotting 24-36 h after transfection. 
 
Fluorescence-activated cell sorting (FACS) 
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Cells were trypsinized, washed with cold PBS, and fixed with 70% ethanol in PBS at 
−20 °C. Samples were washed with cold PBS, resuspended in propidium iodide solution (50 µg/ml) 
containing RNase A (1 mg/ml) and incubated at 37 °C for 30 min. Nuclear DNA content of 104 cells 
were analyzed using FACS calibur system (Becton Dickinson) with CellQuest software (BD 
Biosciences Japan).  
 
Fluorescence immunostaining 
Cells were fixed with 4% paraformaldehyde and immunostained with antibodies against 
Lamin A/C and -tubulin. Double staining was done with Alexa488- and Alexa594-conjugated 
secondary antibodies and the nuclei were counterstained with 4′, 6-diamino-2-phenylindole (DAPI). 
Images were captured using a BIOREVO BZ-9000 fluorescence microscope (Keyence, Tokyo, 
Japan). I determined cells as binucleate based on the structure of microtubule and nuclear matrix.  
 
Patients 
A total of 182 unselected Japanese patients with primary gastric cancer, who underwent a 
gastrectomy between 1994 and 2006 at the Department of Surgery and Science, Graduate School of 
Medical Sciences, Kyushu University Hospital, Fukuoka, were included in this study. None of the 
patients had been treated preoperatively with cytotoxic drugs. Informed consent was obtained from 
each patient.  
 
Immunohistochemical staining 
Immunohistochemical staining was performed according to a previously described protocol 
(Ando et al. 2010). Briefly, the sections were placed in 10 mM citrate buffer (pH 6.0) and boiled in a 
microwave for epitope retrieval. Endogenous peroxidase activity was quenched by incubation in 0.3% 
H2O2. After the blocking with 10% goat serum in PBS, the sections were incubated with a primary 
antibody. Streptavidin–biotin–peroxidase staining was performed using Histofine SAB-PO (M) 
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immunohistochemical staining kit (Nichirei, Tokyo, Japan), according to manufacturer’s instructions. 
Sections were counterstained with Mayer’s hematoxylin and examined at magnification of 400×. 
The p53 expression status was classified by examining immunostaining intensity as 
previously described (Kakeji et al. 1993, Elledge et al. 1994). A distinct nuclear immunoreactivity for 
p53 was recorded as positive, and the nuclear staining pattern was usually diffuse. For tumors that 
showed heterogeneous staining, the predominant pattern was used for scoring. Cases with less than 
10% of positively stained cancer cell nuclei were defined as negative, and the rest as positive (Fig.7). 
The BubR1 expression status was analyzed by examining immunostaining intensity as 
previously described (Ando et al. 2010). BubR1 expression level in lymph follicles, which were 
equally stained in all samples, was assigned an expression score of 1. Weaker staining was assigned 
score of 0, and samples with stronger staining than that seen in the follicles were given score of 2 
(Fig.7).  
 
 
Analysis of DNA ploidy by Laser scanning cytometry  
Nuclear DNA content of gastric cancer samples was measured using laser scanning 
cytometry (CompuCyte, Westwood, MA, USA) as described previously (Kamada et al. 1997). The 
samples came from the same paraffin-embedded blocks as those used for immunohistochemical 
staining. A DNA content histogram was generated and DNA ploidy was determined. DNA index (DI) 
was calculated according to previously published principles (Furuya et al. 2000). The nuclei were 
examined after each scan to exclude debris and attached nuclei from the analysis. The DI of G0/G1-
phase of lymphocytes or fibroblasts was used as a reference DI = 1.0. Tumors with a DI <1.2 were 
defined as diploid; DI ≥1.2 or multi-indexed samples were defined as aneuploid. 
 
Statistical analysis  
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Statistical analysis was performed using the JMP 8.0 statistical software package (SAS 
Institute, Cary, NC, USA). The Student’s t-test and Pearson's chi-square test were used wherever 
appropriate. 
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Results 
OS activated p53 signaling pathway and suppressed the expression of BubR1 and Mad2 
Previous studies indicate that p53 could regulate BubR1 expression (Oikawa et al. 2005, 
Schvartzman et al. 2011). To examine the relationship of OS-activated p53 signaling pathway and 
BubR1 expression, I cultured human diploid fibroblast MRC5 cells in the presence of oxidant agent 
KBrO3 for as long as 48 h and analyzed the p53 signaling pathway and BubR1 expression by Western 
blot. As reported previously (Zhang et al. 2010), both low concentration (0.1 mM) and high 
concentration (1 mM) of KBrO3 induced phosphorylation of p53 Ser15 and accumulation of p53 and 
p21 proteins (Fig. 8A). Concomitantly, KBrO3 suppressed BubR1 expression (Fig. 8A). To examine 
whether reactive oxygen species (ROS) was responsible for these events or not, I added ROS 
scavenger N-acetylcysteine (NAC) before MRC5 cells were exposed to 0.1 mM KBrO3. Neither 
KBrO3-induced accumulation of p53 and p21 protein nor decrease of BubR1 protein was observed in 
the presence of NAC (Fig. 8B). The expression of Mad2, another mitotic checkpoint protein, was also 
downregulated by KBrO3, (Fig. 8A) and the Mad2 downregulation was also cancelled by NAC (Fig. 
8B). These observations indicate that OS activated p53 signaling pathway and suppressed the 
expression of BubR1 and Mad2 through the action of ROS.  
 
OS-induced downregulation of BubR1 and Mad2 expression was p53 dependent 
To examine the relevance of p53 signaling pathway for the decrease of BubR1 and Mad2 
expression under OS, I used MRC5 cells in which p53 had been knocked down by its specific siRNA 
before exposure to KBrO3. Knockdown of p53 inhibited p21 protein expression (Fig. 9A). In this 
condition, the decrease of BubR1 and Mad2 protein under OS was not observed (Fig. 9A). OS-
induced downregulation of BubR1 and Mad2 was detected also at mRNA level and p53 knockdown 
abrogated BubR1 and Mad2 mRNA downregulation (Fig. 9B and 9C). I also observed downregulation 
of BubR1 by KBrO3 in p53-proficient gastric cancer cell lines (MKN45 cell and SNU-1 cell), but not 
in p53-mutant or p53-null gastric cancer cell lines (MKN28 cell and KATOⅢ cell) (Fig.10). These 
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results suggest that the decrease of BubR1 and Mad2 expression under OS was dependent on p53 
signaling pathway.  
 
Suppression of BubR1 expression prevent OS-induced polyploidization in p53-depleted cells    
Dysfunction of p53 signaling pathway is strongly correlated with aneuploidy (Li et al. 
2010). I analyzed the DNA content by FACS of MRC5 cells, which were transfected with p53 and/or 
BubR1 siRNA and exposed to 0.1 mM KBrO3 (Fig.11). SiRNA-mediated downregulation of p53 and 
BubR1 was confirmed by Western blot (Fig. 11A). In the non-treated or the control siRNA-treated 
MRC5 cells, polyploid cells (cells with > 4N DNA content) were decreased significantly when cells 
were cultured in the presence of 0.1 mM KBrO3 (p < 0.05) (Fig.11B and 11C-d). These results were 
probably caused by OS-induced, p53-dependent accumulation of cells in G1 phase and decrease of 
cells in S to G2/M phase (Fig. 11C-a,b and c). In contrast, when p53 expression was knocked-down 
by siRNA, neither accumulation in G1 phase, decrease of cells in S to G2/M phase nor decrease of 
polyploid cells was observed under the same condition (Fig. 11B and 11C). Polyploid cells are 
usually generated when DNA synthesis occurs without proper cell division. To identify the events for 
the generation of polyploid cells in the presence of 0.1 mM KBrO3 in p53 knocked-down cells, I 
observed the nuclear structure of KBrO3-treated cells under the fluorescence microscope. Significant 
increase of binucleate cells was detected by expouse of KBrO3 in p53 knocked-down cells (Fig.3D 
and 3E), but not in control siRNA-treated cells (Fig. 11E). When p53 and BubR1 expression was 
knocked-down at the same time, decrease of cells in S phase and polyploid cells by KBrO3 was 
observed (Fig. 11C-b and d). Consistently, KBrO3 did not increase binucleate cells in this case (Fig. 
11E). In contrast, interestingly, Mad2 knock down did not suppress the emergence of polyploid cells 
by 0.1 mM KBrO3 in p53-depleted cells (Fig.12). These results indicate that BubR1 could be one of 
the essential factors of OS-induced polyploidization in p53-depleted cells. My results also suggest that 
the function of BubR1 required for OS-induced polyploidy might not be related to that of SAC, which 
is largely mediated by Mad2.  
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Relationship between p53 and BubR1 expression status, and DNA aneuploidy in gastric cancer 
specimens 
My data from in vitro experiments indicate that BubR1 is involved in the OS-induced 
polyploidization in p53-deficient cells. Polyploid cells are known to result in aneuploidy and promote 
tumor development (Andreassen et al. 2001, Fujiwara et al. 2005, Roh et al. 2008). To examine 
whether the correlation among p53 dysfunction, BubR1 expression and OS-induced aneuploidy is 
observed in clinical tumor specimens or not, I chose gastric cancer, because gastric mucosa is 
constantly exposed to strong acid and OS might play an important role in gastric organic disorders, 
including cancer (Suzuki et al. 2012). I immunohistochemically stained p53 and BubR1 in 182 gastric 
cancer specimens as previously described (Kakeji et al. 1993, Ando et al. 2010) and examined the 
correlation between them. I regarded p53-positive stained samples as p53 functional loss samples as 
previously described (Starzynska et al. 1992, Kakeji et al. 1993, Kupryjanczyk et al. 1993, Dix et al. 
1994). Among 71 specimens with p53-negative staining, 45 specimens (63.4%) showed high BubR1 
expression (score: 1, 2). In contrast, among 111 specimens with p53-positive staining, 95 specimens 
(85.6%) showed high BubR1 expression (p < 0.01; Table 3). These results suggest that BubR1 tends 
to be highly expressed when p53 function was lost in gastric cancer. 
Next, I investigated the relationship between p53/BubR1 expression and DNA aneuploidy in 
gastric cancer. Using Laser Scanning Cytometer, I have analyzed DNA contents in 77 specimens: 13 
specimens with p53-negative staining and low BubR1 expression (score: 0), and 64 specimens with 
p53-positive staining and high BubR1 expression (score: 1, 2). Among 44 specimens that exhibited 
aneuploidy, 41 specimens (93.2%) showed p53-positive staining and high BubR1 expression (p < 
0.01; Table 4). This significant correlation between coexistence of p53 dysfunction and high 
expression of BubR1 and DNA aneuploidy in gastric cancer may support my results from in vitro 
experiments.  
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Figure 7. Expression of p53 and BubR1 in gastric cancer.   
The Immunohistochemical staining figure of four specimens is shown. (Left line: x100, Right line: 
x400 in magnification) Scale bars, 100 µm. (A) p53-negative staining/ low BubR1 expression (score: 
0) specimen (B) p53-negative staining/ high BubR1 expression (score: 1) specimen (C) p53-negative 
staining/ BubR1 expression (score: 2) specimen (D) p53-positive staining/ BubR1 expression (score: 
2) specimen  
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Figure 8. OS induced p53 signaling pathway and suppressed the expression of BubR1 and Mad2 
(A) MRC5 cells were exposed to 0.1 or 1mM KBrO3 for 0 to 48 h. Each protein was analyzed by 
Western blotting. (B) Effect of ROS scavenge on p53 signaling pathway and the expression of BubR1 
and Mad2 under OS. MRC5 cells were incubated with 1mM NAC (N-acetylcysteine) prior to KBrO3 
treatment for 15min and exposed to 0.1mM KBrO3. After 48h incubation, cells were collected and 
analyzed by Western blotting. -actin is shown as a loading control. 
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Figure 9. OS-induced downregulation of BubR1 and Mad2 expression is p53 dependent. 
MRC5 cells were transfected with control siRNA or p53 siRNA, and after 24h incubation, 0.1mM 
KBrO3 was added. (A) Western blot analysis of p53, p21, BubR1 and Mad2 in MRC5 cells after 48h 
of KBrO3 addition. (B) Relative expression of BubR1 and Mad2 by q-PCR. Knockdown of p53 
increased the expression of BubR1 and Mad2 mRNA under OS. The expression scores were 
normalized to -actin. Relative expression level to non-transfected under no-OS sample is shown. 
Data are shown as mean ± S.D. of triplicate measurements. *p<0.05 
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Figure 10. The response to KBrO3 in gastric cancer cell lines with or without p53 signal 
dysregulation. 
Four gastric cancer cell lines were exposed to 2mM KBrO3 for 0 to 48 h. Each protein was analyzed 
by Western blotting. In p53-proficient gastric cancer cell lines (MKN45 cell and SNU-1 cell), KBrO3 
induced phosphorylation of p53 Ser15 and accumulation of p53 and p21 protein. Concomitantly, 
KBrO3 suppressed the expression of BubR1. In p53-mutant cell line or p53-null gastric cancer cell 
lines (MKN28 cell and KATOⅢ cell), the accumulation of p21 proteins were not induced and the 
decrease of BubR1 expression was not observed by KBrO3 exposure. 
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Figure 11. Suppression of BubR1 expression prevents OS-induced polyploidization in p53-depleted 
cells 
(A) MRC5 cells were transfected with cont. siRNA, p53 siRNA and BubR1 siRNA, and after 36h 
incubation, siRNA-mediated downregulation of p53 and BubR1 was confirmed by Western blot.  
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(B) MRC5 cells were transfected with cont. siRNA, p53 siRNA and BubR1 siRNA, and after 36h 
incubation, 0.1mM KBrO3 was added. Cell cycle distribution and DNA content were analyzed by 
flow cytometory. Percentage of cells with >4N DNA content is shown. (C) Changes of cells in each 
cell cycle by 0.1mM KBrO3. Relative percentages of 0.1mM KBrO3–treated cells in G1 phase (2N, a), 
S phase (2N<, <4N, b), G2/M phase (4N, c) and polyploidy (4N<, d) are shown as filled black bar. * 
p<0.05. Data are shown as mean±S.D. of triplicate measurements. (D) A binucleate cell (nuclei 
shown by arrowheads) in p53-knockdown MRC5 cells with KBrO3 exposure. Merged 
immunofluorescence image of -tubulin (red), Lamin A/C (green) and DAPI (blue) is shown. Scale 
bar, 100 µm. (E) Percentage of binucleate cells. * p<0.05. 
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Figure 12. Suppression of Mad2 expression dose NOT contribte to prevent OS-induced 
polyploidization in p53-depleted cells 
 
MRC5 cells were transfected with cont. siRNA, p53 siRNA and Mad2 siRNA, and after 36h 
incubation, 0.1mM KBrO3 was added. Cell cycle distribution. DNA content was analyzed by flow 
cytometory. Changes of cells in each cell cycle by 0.1mM KBrO3. Relative percentages of 0.1mM 
KBrO3–treated cells in G1 phase (2N), S phase (2N<, <4N), G2/M phase (4N) and polyploidy (4N<) 
are shown as filled black bar. 
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Table 3. P53 expression status and BubR1 expression level in gastric cancer 
 
The values in parentheses are expressed in %. *p<0.01 
 
Table 4. DNA ploidy and BubR1/ p53 expression status in gastric cancer 
 
The values in parentheses are expressed in %. *p<0.01 
  
55 
 
Discussion 
It has been proposed that OS might contribute to carcinogenesis by increasing the frequency 
of genetic mutations, and that the reactive oxygen species, ROS, act as second messengers in multiple 
intracellular pathways, resulting in malignant transformation (Ralph et al. 2010). Possible models that 
connect DNA aneuploidy with OS has been proposed (Gorla et al. 2001, Kraniak et al. 2006). 
However, the role of OS in DNA aneuploidy is still controversial. In my in vitro analysis using 
normal human fibroblast MRC5 cell, when p53 expression was suppressed, OS-producing drug 
KBrO3 increased polyploid cells, which was partially dependent on sustained expression of BubR1 
(Fig. 11). Consistently, I also found that the coexistence of p53 dysfunction and high expression of 
BubR1 strongly correlated with the extent of aneuploidy in gastric cancer specimens (Table 4).  
I found that OS activated the p53 signaling pathway and downregulated the expression of 
BubR1 and Mad2 (Fig.8). BubR1 and Mad2 downregulation by OS was p53-dependent (Fig.9 and 
Fig.10). During the activation of SAC, BubR1 and Mad2 form a complex with, Bub3, and Cdc20, and 
inhibits the proteasome activity of APC/C (Davenport et al. 2006). Accumulation of BubR1 and Mad2 
in the absence of functional p53 may cause accumulation of APC/C substrates (Cyclin A/B, Securin, 
Aurora-A, and Plk1) and may evoke some mitotic errors that induce chromosomal aberrations such as 
polyploidy (Meraldi et al. 2002, Baek et al. 2003, Incassati et al. 2006, Sotillo et al. 2007). P53 could 
play a critical role in the repression of OS-initiated mitotic errors through downregulation of SAC 
factors. In addition, cells lacking p53 function could also have an increased ability to re-enter the cell 
cycle and initiate DNA replication even in cells with incorrect chromosome number. Such p53 
deficiency and SAC accumulation may cause polyploidization and the emergence of cells with > 4N 
DNA content. Polyploidy is considered pro-tumorigenic as it leads to chromosomal instability that 
can contribute to tumor development (Fujiwara et al. 2005, Roh et al. 2012). Thus, my results may 
implicate a novel and critical role of p53 to suppress tumorigenesis associated DNA aneuploidy under 
OS.  
BubR1 knockdown decreased the emergence of polyploid cells significantly under OS in 
p53-depleted cells (Fig. 11B and 11C-d). Insufficient amount of BubR1 is known to lead to inactivate 
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SAC function resulting in incidence of DNA aneuploidy (Baker et al. 2004, Matsuura et al. 2006). My 
result was consistent with these reports in that BubR1 downregulation itself increased binucleate cells 
in p53-depleted cells in normal culture condition (Fig. 11E). However, my results also suggest that the 
downregulation of BubR1 suppress the emergence of polyploid cells caused by OS when p53 was 
suppressed (Fig. 11C-b). Interestingly, downregulation of Mad2 did not suppress the emergence of 
polyploid cells caused by OS when p53 was suppressed (Fig.12). Currently, the underlying 
mechanism is still unclear, but recently, as a new role of BubR1 in other than SAC, Baker et al. 
demonstrated that the reduction in BubR1 levels causes cell senescence by activating the p16Ink4a-Rb 
signaling pathway in mouse model (Baker et al. 2011). Miyamoto et al. also demonstrated that BubR1 
is required for ubiquitin-mediated proteasomal degradation of CDC20 in the G0 phase and maintains 
APC/CCDH1 activity (Miyamoto et al. 2011). Such novel function of BubR1 might contribute to the 
phenotype I observed. 
In clinical gastric cancer specimens, I found that BubR1 expression level was strongly 
correlated with p53 dysfunction (Table 3) and the coexistence of p53 dysfunction and high expression 
of BubR1 was significantly accompanied with DNA aneuploidy (Table 4). These results suggest that 
p53 signaling pathway might also regulate BubR1 expression under OS in vivo and the failure of this 
regulation might contribute to the increase of DNA aneuploidy. The increase of OS was observed in 
aneuploid cells and ROS accumulation could have a role in maintaining aneuploidy formation (Li et 
al. 2010, Roh et al. 2012). The stomach is a digestive organ subjected to OS directly or indirectly 
because of the diet, and some gastric organic disorders, including cancer, could be related to such 
stress (Suzuki et al. 2012). Therefore cumulative effects of OS in aneuploid cells could promote 
gastric carcinogenesis. 
A possible model of gastric carcinogenesis associated with DNA aneuploidy was 
schematically shown in Fig. 13. When p53 is fully functional, OS does not evoke polyploidization. 
P53-dependent BubR1 and Mad2 downregulation could be one of the reasons to suppress 
polyploidization (Fig.13A). In contrast, p53 deficiency may lead to the failure of BubR1 and Mad2 
downregulation and accumulated BubR1 or Mad2 could contribute to enhance binucleation and 
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polyploidization, which will be the trigger of chromosome missegregation and aneuploidy, and, 
possibly, will promote tumorigenesis (Fig.13B). Importantly, BubR1 downregulation was able to 
suppress OS-induced binucleation and polyploidization even in p53-depleted cells (Fig.13C), 
suggesting the possibility for BubR1 as a molecular target for prevention of tumorigenesis through 
p53 dysfunction and OS-induced aneuploidy. Thus, my findings may have a clinical implication for 
suppressing gastric carcinogenesis associated with DNA aneuploidy. 
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Figure 13. A possible model of gastric carcinogenesis associated with DNA aneuploidy 
When p53 is fully functional, OS does not envoke polyploidization. P53-dependent BubR1 and Mad2 
downregulation could be one of the factors that contribute to suppress polyploidization (A). In 
contrast, p53 deficiency may lead to the failure of BubR1 and Mad2 downregulation and OS induced 
aneuploidy (B). BubR1 itself may contribute to enhance OS-induced polyploidization, because 
siRNA-mediated downregulation of BubR1, but not of Mad2, could suppress OS-induced 
polyploidization (C). Consistently, coexistence of p53 dysfunction and high expression of BubR1 are 
frequently observed in gastric cancer specimens with aneuploidy, which suggests the involvement in 
gastric cancinogenesis associated with DNA aneuploidy. 
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General Discussion 
 Mad3/BubR1 was first identified in mutated S. cerevisiae in which the cell cycle progressed 
even after administration of the microtubule polymerization inhibitor benzimidazole (Hoyt et al. 
1991), and was demonstrated to play a central role in SAC function (Li et al. 1991, Tang et al. 2001, 
Musacchio et al. 2007). The SAC function of yeast Mad3 has since been confirmed in homologs in 
various eukaryotic species (Basu et al. 1998, Cahill et al. 1998, Chen 2002). In tumor cells, the SAC 
function of BubR1 avoids lethality due to massive chromosome loss (Dorer et al. 2005, Kops et al. 
2004). In addition to its SAC function, other functions related to cell division have been reported for 
BubR1. It determines basal mitotic timing, or the minimum time that elapses between nuclear 
envelope breakdown and anaphase onset, even when there are no unattached kinetochores (Meraldi et 
al. 2004). Furthermore, it promotes proper kinetochore-microtubule attachment (Lampson et al. 
2005). The multifunctionality of BubR1 has complicated phenotypic interpretation during mitosis. 
However, when specific mutations that affect only one function but leave the others relatively intact 
were introduced into BubR1, these functions were shown to be independent (Rahmani et al. 2009). 
These studies suggest that BubR1 plays an active, multifunctional role in ensuring accurate 
chromosome separation during mitosis. 
As described above, BubR1 localizes to the kinetochore during the mitotic phase and is involved in 
chromosome division (Musacchio et al. 2007). On the other hand, it has been reported that in several 
cell lines, BubR1 localizes to the centrosome during interphase and is involved in cilia formation and 
centrosome replication (Miyamoto et al. 2011, Matsumoto et al. 2009), suggesting that BubR1 has 
multiple functions during the whole cell cycle. Moreover, BubR1 is revealed to be involved in various 
cellular phenomena such as cell senescence (Baker et al. 2004), expression of cell adhesion factors, 
and proliferation of tetraploid cells, the last two of which have been shown in this study, however, 
which cell cycle each of the phenomena is dependent on is unknown. What is the essential 
physiological function of BubR1 underlying these multiple functions? I believe that the multifaceted 
role of BubR1 might be closely related to the function of microtubules. Microtubules are constituents 
of the cytoskeleton and play a role not only in maintaining and changing the shape of cells, but also in 
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the transport of substances within cells, formation of cell organelles, cell cycle progression, and cell 
differentiation (Muroyama et al. 2017, Salogiannis et al. 2017, Werner et al. 2017). Microtubules are 
hollow cylindrical fibers composed of/tubulin heterodimers, and are highly dynamic structures 
that can stretch and shrink within cells due to polymerization and depolymerization (Fig. 14A). 
Microtubules are produced at the Microtubule Organizing Center, which is the centrosome in animal 
cells, and most interstitial microtubules extend radially from the centrosome during interphase (Fig. 
14B). Since transport motor proteins move on microtubules, they play an important role in 
intracellular material transport. Microtubules themselves can cause cell cycle-dependent 
morphological changes (Fig. 14C). Cilia/flagella are organelles composed of microtubules and are 
formed during G0/G1 phase. Cilia/flagella withdraw when cells enter S phase, following which 
centrosome replication occurs and the microtubule network is restructured. For subsequent 
chromosome division, the duplicated centrosomes move to the two poles of the cell, nucleating 
microtubules, which bundle to form the mitotic spindle. The spindles capture the chromosomes, bind 
kinetochores and microtubules, and pull the chromosomes apart, using well-organized system. I 
noticed that this cell cycle-dependent microtubule change overlaps with the cellular phenomenon 
involving BubR1 (Izumi et al. 2009, Lampson et al. 2005, Musacchio et al. 2007, Miyamoto et al. 
2011)(Fig. 14B, C). In addition, the mechanism of cellular senescence due to cilia dysplasia has been 
reported (Li et al. 2011, Inoko et al. 2012), highlighting the possibility that cellular senescence 
induced by the low expression of BubR1 is caused by ciliary dysplasia. Further, it has been reported 
that in the course of cell differentiation, the expression level of the cell adhesion factor is regulated 
depending on microtubule transport (Lechler et al. 2007). The suppression of DSC1 expression due to 
the low expression of BubR1 is also considered to be mediated by the transport function of 
microtubules. Therefore, I believe that the essential physiological function of BubR1 might be to 
maintain homeostasis in microtubule function. In the future, I would like to work to verify this 
hypothesis and investigate the influence of BubR1 on the signals required for cell cycle-dependent 
microtubule changes and the factors related to microtubule transport. 
 
61 
 
Figure 14. Microtubule function and BubR1 involvement 
(A) Microtubules are hollow cylindrical fibers composed of/tubulin heterodimers, and are highly 
dynamic structures that can stretch and shrink within cells due to polymerization and 
depolymerization. (B) Microtubules are produced at the Microtubule Organizing Center, which is the 
centrosome in animal cells, and most interstitial microtubules extend radially from the centrosome 
during interphase. Transport motor proteins move on microtubules, they play an important role in 
intracellular material transport. (C) Microtubules cause cell cycle-dependent morphological changes.  
Red letters are the cellular phenomenon in which the involvement of BubR1are reported or are 
suggested. 
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In addition to MVA/PCS syndrome, which is caused by insufficient BubR1 expression and 
SAC dysfunction (Hanks et al. 2004, Matsuura et al. 2006), various diseases have been linked to 
BubR1 functions, such as senescence through the dysregulation of p16Ink4a expression (Baker et al. 
2008, Baker et al. 2011) and impaired ciliogenesis through abnormal APC/C-CDH1 activation 
(Miyamoto et al. 2011). I investigated the physiological relevance of BubR1 in liver regeneration 
using mice expressing low levels of BubR1, and discovered a novel function for BubR1 in the 
regulation of DSC1 expression. Delay of liver regeneration due to aging and hepatic disorders may 
have been caused by abnormal DSC1 expression due to BubR1 insufficiency. 
Since various diseases are associated with low BubR1 expression, increasing its expression 
might have therapeutic potential. However, this approach may increase the risk of carcinogenesis, as 
high BubR1 expression with p53 dysfunction may lead to cell proliferation and tumor growth. There 
are numerous reports that high levels of BubR1 may be a prognostic marker for tumor recurrence and 
disease progression (Yuan et al. 2006, Burum-Auensen et al. 2007, Yamamoto et al. 2007). The 
development of inhibitors that target the C-terminal kinase domain of BubR1 is underway, but side 
effects are predicted due to lack of specificity (Kapanidou et al. 2015). Unfortunately, no drug 
targeting BubR1 itself has been successfully developed. Therefore, targeting the factors affecting each 
function downstream of BubR1 may be more desirable to produce safer drugs. 
Despite the discovery of several SAC-independent functions for BubR1, examination of the 
relationships between the various functions of BubR1 has not been performed. It remains unknown 
whether these functions are independent or correlated with each other, or whether the presence and 
absence of essential regions of BubR1 are important for multiple functions. Structure-function studies 
to locate the specific regions in BubR1 upon which each function depends will be necessary. Further 
clarification of the interplay between different BubR1 functions at the molecular level will lead to the 
elucidation of new disease mechanisms related to BubR1, and contribute to the development of 
effective treatments for BubR1-related diseases.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
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